Invesco’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$451K Sell
375,886
-3,139
-0.8% -$3.82K ﹤0.01% 3204
2025
Q4
$372K Buy
379,025
+64,200
+20% +$77.1K ﹤0.01% 3308
2025
Q3
$397K Buy
314,825
+59,453
+23% +$64.1K ﹤0.01% 3315
2025
Q2
$286K Buy
255,372
+41,869
+20% +$48.7K ﹤0.01% 3379
2025
Q1
$169K Buy
213,503
+104,569
+96% +$128K ﹤0.01% 3549
2024
Q4
$180K Buy
108,934
+7,056
+7% +$17.8K ﹤0.01% 3535
2024
Q3
$357K Sell
101,878
-218
-0.2% -$848 ﹤0.01% 3359
2024
Q2
$335K Sell
102,096
-863,335
-89% -$3.78M ﹤0.01% 3452
2024
Q1
$7.09M Buy
965,431
+835,977
+646% +$5.17M ﹤0.01% 2019
2023
Q4
$484K Buy
129,454
+3,867
+3% +$9.13K ﹤0.01% 3237
2023
Q3
$266K Buy
125,587
+6,791
+6% +$22.5K ﹤0.01% 3503
2023
Q2
$565K Sell
118,796
-4,465
-4% -$24.6K ﹤0.01% 3173
2023
Q1
$703K Buy
123,261
+75,782
+160% +$457K ﹤0.01% 3086
2022
Q4
$479K Sell
47,479
-3,687
-7% -$69.2K ﹤0.01% 3290
2022
Q3
$1.15M Buy
51,166
+3,616
+8% +$104K ﹤0.01% 2874
2022
Q2
$1.18M Sell
47,550
-967,567
-95% -$26.7M ﹤0.01% 2921
2022
Q1
$39.4M Buy
1,015,117
+131,838
+15% +$5.11M 0.01% 1108
2021
Q4
$51.7M Buy
883,279
+762,832
+633% +$43.2M 0.01% 1034
2021
Q3
$7.14M Sell
120,447
-763,687
-86% -$59.9M ﹤0.01% 2200
2021
Q2
$76.7M Buy
884,134
+206,998
+31% +$16.7M 0.02% 919
2021
Q1
$55.8M Buy
677,136
+253,280
+60% +$24.3M 0.01% 1014
2020
Q4
$38.5M Buy
423,856
+102,309
+32% +$6.35M 0.01% 1113
2020
Q3
$12.9M Buy
321,547
+296,773
+1,198% +$10.4M ﹤0.01% 1529
2020
Q2
$850K Sell
24,774
-122,688
-83% -$3.66M ﹤0.01% 2865
2020
Q1
$3.27M Buy
+147,462
New +$3.73M ﹤0.01% 2120
2019
Q3
Sell
-50,107
Closed -$1.02M 3689
2019
Q2
$1.02M Sell
50,107
-3,072
-6% -$55.4K ﹤0.01% 3068
2019
Q1
$934K Sell
53,179
-17,683
-25% -$279K ﹤0.01% 3058
2018
Q4
$909K Sell
70,862
-515,916
-88% -$7.19M ﹤0.01% 3028
2018
Q3
$9.56M Buy
586,778
+404,542
+222% +$4.78M ﹤0.01% 1731
2018
Q2
$2.07M Buy
+182,236
New +$2.01M ﹤0.01% 2734
2017
Q3
Sell
-20,736
Closed -$67K 3652
2017
Q2
$67K Buy
20,736
+8,271
+66% +$31.7K ﹤0.01% 3658
2017
Q1
$57K Buy
+12,465
New +$45.6K ﹤0.01% 3682

Other funds holding FATE